Exact Mass: 355.0975148
Exact Mass Matches: 355.0975148
Found 78 metabolites which its exact mass value is equals to given mass value 355.0975148,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2,5-diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one
2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one is a member of the class of compounds known as monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one can be found in a number of food items such as abiyuch, saffron, natal plum, and pasta, which makes 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one a potential biomarker for the consumption of these food products. 2,5-diamino-6-(5-phospho-d-ribitylamino)pyrimidin-4(3h)-one may be a unique S.cerevisiae (yeast) metabolite.
Avenanthramide P
2-[4-(1,3-Dithiolan-2-yl)phenoxy]-N-{[(isopropylamino)carbonyl]oxy}ethanimidamide
3-[2-Methyl-1,2,3,4-tetrahydro-6,7-(methylenebisoxy)isoquinoline-1-yl]-6,7-dihydroxyisobenzofuran-1(3H)-one
Methanone, (7,8-dihydro-1,3-dioxolo(4,5-g)isoquinolin-5-yl)(2-hydroxy-3,4-dimethoxyphenyl)-
(6-Bromo-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-4-yl)-carbamic acid tert-butyl ester
(6-Bromo-3,4,5,6-tetrahydro-2H-[1,2]bipyridinyl-3-yl)-carbamic acid tert-butyl ester
N-(9-Fluorenylmethoxycarbonyl)-L-aspartic acid-1-13C
ethyl 3-(naphthalen-2-ylsulfonylamino)benzoate
C19H17NO4S (355.08782420000006)
N-(1-Naphthalenesulfonyl)-L-phenylalanine
C19H17NO4S (355.08782420000006)
tinofedrine
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine
C14H18ClN5O4 (355.10472580000004)
tert-butyl 4-(6-bromopyridin-2-yl)-1,4-diazepane-1-carboxylate
5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione
C18H17N3O3S (355.09905720000006)
1-(azetidin-3-yl)-4-(4-methoxyphenyl)piperazine,trihydrochloride
3-[4-(2-Methoxyphenyl)piperazinyl]azetidine trihydrochloride
tert-Butyl 4-(3-bromo-5-methylpyridin-2-yl)piperazine-1-carboxylate
N-Succinimidyl 3-(Diphenylphosphino)propionate
C19H18NO4P (355.09733980000004)
{(2z)-4-Amino-2-[(4-Methoxyphenyl)imino]-2,3-Dihydro-1,3-Thiazol-5-Yl}(4-Methoxyphenyl)methanone
C18H17N3O3S (355.09905720000006)
2-[[3-(3,4-Dimethoxyphenyl)-2-oxo-1-benzopyran-7-yl]oxy]acetamide
7-Carboxy-5-Hydroxy-12,13-Dihydro-6h-Indolo[2,3-A]pyrrolo[3,4-C]carbazole
C21H13N3O3 (355.09568680000007)
14-Oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaene-12-carboxylic acid
C21H13N3O3 (355.09568680000007)
2-{5-[2-(1H-Benzoimidazol-2-yl)-2-cyano-vinyl]-furan-2-yl}-benzoic acid
C21H13N3O3 (355.09568680000007)
N-[2-(1H-benzimidazol-2-yl)ethyl]-3,5-dinitrobenzamide
C16H13N5O5 (355.09166480000005)
N-[5-(2,4-dimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-phenylacetamide
C18H17N3O3S (355.09905720000006)
N-[2-(1-naphthalenyl)-1,3-benzoxazol-5-yl]-1H-1,2,4-triazole-5-carboxamide
2-[(4-Oxo-2-pyrido[1,2-a]pyrimidinyl)methylthio]-3-pyridinecarboxylic acid propan-2-yl ester
C18H17N3O3S (355.09905720000006)
2-[(1-acetyl-2-benzimidazolyl)thio]-N-(2-methoxyphenyl)acetamide
C18H17N3O3S (355.09905720000006)
N-(4-methylphenyl)-2-[(4E)-4-[(5-methylthiophen-2-yl)methylidene]-2,5-dioxoimidazolidin-1-yl]acetamide
C18H17N3O3S (355.09905720000006)
1-[2-[(4-Chlorophenyl)thio]-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester
C17H22ClNO3S (355.1008852000001)
4-[[3-Cyano-4-methyl-6-(3-pyridinyl)-2-pyridinyl]thio]-3-oxobutanoic acid ethyl ester
C18H17N3O3S (355.09905720000006)
N-(3-methylphenyl)-2-{(4E)-4-[(5-methylthien-2-yl)methylene]-2,5-dioxoimidazolidin-1-yl}acetamide
C18H17N3O3S (355.09905720000006)
3-chloro-4,5-dimethoxy-N-(1-naphthalenylmethyl)benzamide
(2S)-2-[2-[(1S,6S)-5-carboxy-6-hydroxycyclohexa-2,4-dien-1-yl]oxyprop-2-enoylamino]pentanedioic acid
C15H17NO9 (355.09032720000005)
2,5-diamino-6-(5-phosphono)ribitylamino-4(3H)-pyrimidinone
A 1-deoxy-D-ribitol-5-phosphate having a (5,6-diamino-4-oxopyrimidin-2-yl)amino group at the 1-position.
VU0152099
C18H17N3O3S (355.09905720000006)
VU0152099 is a potent, selective and brain-penetrant mAChR M4 positive allosteric modulator with an EC50 of 0.4 μM for rat M4 receptor. VU0152099 is inactive for other mAChR subtypes or other GPCRs. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine[1]. VU0152099 is a potent, selective and brain-penetrant mAChR M4 positive allosteric modulator with an EC50 of 0.4 μM for rat M4 receptor. VU0152099 is inactive for other mAChR subtypes or other GPCRs. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine[1].
4-(1h-indol-3-yl)-5-oxo-6h-azepino[4,5-b]indole-2-carboxylic acid
C21H13N3O3 (355.09568680000007)
7-[(dimethylamino)methyl]-5,12-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione
1-(1h-indole-3-carbonyl)-9h-pyrido[3,4-b]indole-3-carboxylic acid
C21H13N3O3 (355.09568680000007)
10-(6,7-dihydroxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl)-3,5,11-trioxatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),7-trien-12-one
6-hydroxy-7-methoxy-12-methyl-16,18-dioxa-12-azatetracyclo[11.7.0.0⁴,⁹.0¹⁵,¹⁹]icosa-1(20),4(9),5,7,13,15(19)-hexaene-2,3-dione
(4s)-4-hydroxy-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,7,9(17),13,15-pentaene-3,11,12-trione
6-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h-indole-2-carboxylic acid
C15H17NO9 (355.09032720000005)
(3s,6r,8s,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,11,13,15,17(21)-pentaene-6,8,13-triol
C18H17N3O3S (355.09905720000006)